Clavien / Trotter Medical Care of the Liver Transplant Patient

4. Auflage 2011
ISBN: 978-1-4443-9841-0
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 496 Seiten, E-Book

This book builds on the success of previous editions, once again providing hepatologists the most current clinical guide on how to best treat the liver transplant recipient. With an international mix of experienced contributors, this new edition highlights initial indication and selection of the potential recipient, management of the donor organ, post-operative complications in the patient through to acute recovery, long-term follow-up, and continued health. This provides the user a complete guide to the correct clinical management of both the recipient and the donor organ through all stages of transplantation.

Autoren/Hrsg.

Clavien, Pierre-Alain

Trotter, James F.

Über Autor(innen)

Pierre-Alain Clavien, MD, PhD, FACS, FRCS (Eng), FRCS (Ed),Professor and Chairman, Department of Surgery. Head, Division ofVisceral & Transplantation Surgery, University Hospital Zurich,Switzerland
Professor Clavien is a world-wide renowned surgeon-scientist,currently professor and chairman of the Department of Surgery inZurich, Switzerland. His areas of research include organpreservation, liver ischemia-reperfusion injury and regeneration,and pathogenesis of cancer, as well as outcome research. Hereceived many competitive grants and awards, including one of themost prestigious prices for scientific research, the Otto NaegeliAward.
Dr James Trotter is the Medical Director of LiverTransplantation at Baylor University Medical Center at Dallas. Dr.Trotter's primary interests include end-stage liver disease and themanagement of liver transplant candidates and recipients. Dr.Trotter specializes in hepatitis C, ascites, complications ofportal hypertension, including esophageal varices and hepaticencephalopathy. He also has vast experience in the management ofmedical complications after liver transplantation includingimmunosuppression in liver transplant recipients and the treatmentof hepatitis C before and after liver transplantation.